Susceptibility of clinical isolates of fungi to saperconazole-Reference-Cited by-同舟云学术

Susceptibility of clinical isolates of fungi to saperconazole

Published:1992-06 Issue:3 Volume:118 Page:179-183
ISSN:0301-486X
Container-title:Mycopathologia
language:en
Short-container-title:Mycopathologia

Author:

Otčenášek Miloš

Publisher

Springer Science and Business Media LLC

Subject

Veterinary (miscalleneous),Agronomy and Crop Science,Applied Microbiology and Biotechnology,Microbiology

Link

http://link.springer.com/content/pdf/10.1007/BF00437152.pdf

Reference11 articles.

1. Otčenášek M. The in vitro susceptibility of some mycotic agents to a new orally active triazole, itraconazole. J Hyg Epidemiol Microbiol Immunol 1990; 34: 129–134.

2. Otčenášek M, Kuklová I. Itraconazole: Characteristics and evaluation of a new systemic antimycotic. Janssen Res News 1991; 16: 2–13.

3. Van Cutsem J, Van Gerven F, Janssen PAJ. Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models. Rev Inf Dis 1987; 9 (Suppl 1): 15–32.

4. Van Cutsem J, Van Gerven F, Janssen PAJ. Saperconazole, a new potent antifungal triazole: in vitro activity spectrum and therapeutic efficacy. Drugs Fut 1989; 14: 1187–1209.

5. Odds FC. Antifungal activity of saperconazole (R 66905) in vitro. J Antimicrob Chemoth 1989; 24: 533–538.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implications of Detecting the Mold Syncephalastrum in Clinical Specimens of New Orleans Residents After Hurricanes Katrina and Rita;Journal of Occupational & Environmental Medicine;2007-04

2. Treatment of Absidia corymbifera infection in mice with amphotericin B and itraconazole;Journal of Antimicrobial Chemotherapy;2001-10-01

3. Zygomycetes in human disease;CLIN MICROBIOL REV;2000

4. Zygomycetes in Human Disease;Clinical Microbiology Reviews;2000-04

5. Clinical Pharmacology of Systemic Antifungal Agents: A Comprehensive Review of Agents in Clinical Use, Current Investigational Compounds, and Putative Targets for Antifungal Drug Development;Advances in Pharmacology;1998